Clinical Trials Directory

Trials / Terminated

TerminatedNCT02647892

Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
70 (actual)
Sponsor
University of Nebraska · Academic / Other
Sex
All
Age
19 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the optimal amount of lidocaine buffering needed to decrease injection pain when administering local anesthesia.

Detailed description

Once the site is chosen, the skin will be anesthetized as usual. This study will utilize a commercially prepared 1% lidocaine solution mixed with standard sodium bicarbonate. A total of 10 mL will be used.

Conditions

Interventions

TypeNameDescription
DRUGlidocainelocal anesthesia
DRUGsodium bicarbonateadditional drug added to lidocaine

Timeline

Start date
2016-01-08
Primary completion
2021-11-05
Completion
2021-11-05
First posted
2016-01-06
Last updated
2023-08-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02647892. Inclusion in this directory is not an endorsement.